Supramolecular co-assembly of self-adjuvanting nanofibrious peptide hydrogel enhances cancer vaccination by activating MyD88-dependent NF-κB signaling pathway without inflammation
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Supramolecular co-assembly of self-adjuvanting nanofibrious peptide hydrogel enhances cancer vaccination by activating MyD88-dependent NF-κB signaling pathway without inflammation
Authors
Keywords
Cancer immunotherapy, Vaccination, Peptide, Co-assembly, Self-adjuvanting
Journal
Bioactive Materials
Volume 6, Issue 11, Pages 3924-3934
Publisher
Elsevier BV
Online
2021-04-16
DOI
10.1016/j.bioactmat.2021.03.041
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Peptide–TLR-7/8a conjugate vaccines chemically programmed for nanoparticle self-assembly enhance CD8 T-cell immunity to tumor antigens
- (2020) Geoffrey M. Lynn et al. NATURE BIOTECHNOLOGY
- A bi-adjuvant nanovaccine that potentiates immunogenicity of neoantigen for combination immunotherapy of colorectal cancer
- (2020) Qianqian Ni et al. Science Advances
- Delivery technologies for cancer immunotherapy
- (2019) Rachel S. Riley et al. NATURE REVIEWS DRUG DISCOVERY
- Hierarchically oriented organization in supramolecular peptide crystals
- (2019) Chengqian Yuan et al. Nature Reviews Chemistry
- Nucleation and Growth of Amino Acid and Peptide Supramolecular Polymers through Liquid-Liquid Phase Separation
- (2019) Chengqian Yuan et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- MHC-II neoantigens shape tumour immunity and response to immunotherapy
- (2019) Elise Alspach et al. NATURE
- CD4+ T Cell Help Is Required for the Formation of a Cytolytic CD8+ T Cell Subset that Protects against Chronic Infection and Cancer
- (2019) Ryan Zander et al. IMMUNITY
- A facile approach to enhance antigen response for personalized cancer vaccination
- (2018) Aileen Weiwei Li et al. NATURE MATERIALS
- Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma
- (2018) Robert J. Motzer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Personalized vaccines for cancer immunotherapy
- (2018) Ugur Sahin et al. SCIENCE
- CAR T cell immunotherapy for human cancer
- (2018) Carl H. June et al. SCIENCE
- Correlates of adjuvanticity: A review on adjuvants in licensed vaccines
- (2018) Giuseppe Del Giudice et al. SEMINARS IN IMMUNOLOGY
- Actively personalized vaccination trial for newly diagnosed glioblastoma
- (2018) Norbert Hilf et al. NATURE
- Nano-, micro-, and macroscale drug delivery systems for cancer immunotherapy
- (2018) Pingsheng Huang et al. Acta Biomaterialia
- Fine tuning the assembly and gel behaviors of PEGylated polypeptide conjugates by the copolymerization ofl-alanine and γ-benzyl-l-glutamateN-carboxyanhydrides
- (2017) Yumin Zhang et al. JOURNAL OF POLYMER SCIENCE PART A-POLYMER CHEMISTRY
- An immunogenic personal neoantigen vaccine for patients with melanoma
- (2017) Patrick A. Ott et al. NATURE
- Efficient Eradication of Established Tumors in Mice with Cationic Liposome-Based Synthetic Long-Peptide Vaccines
- (2017) Eleni Maria Varypataki et al. Cancer Immunology Research
- Clinical study of a survivin long peptide vaccine (SurVaxM) in patients with recurrent malignant glioma
- (2016) Robert A. Fenstermaker et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Peptide self-assembly: thermodynamics and kinetics
- (2016) Juan Wang et al. CHEMICAL SOCIETY REVIEWS
- The administration route is decisive for the ability of the vaccine adjuvant CAF09 to induce antigen-specific CD8 + T-cell responses: The immunological consequences of the biodistribution profile
- (2016) Signe Tandrup Schmidt et al. JOURNAL OF CONTROLLED RELEASE
- Designer vaccine nanodiscs for personalized cancer immunotherapy
- (2016) Rui Kuai et al. NATURE MATERIALS
- Neoantigens in cancer immunotherapy
- (2015) T. N. Schumacher et al. SCIENCE
- Structure-based programming of lymph-node targeting in molecular vaccines
- (2014) Haipeng Liu et al. NATURE
- Therapeutic vaccines for cancer: an overview of clinical trials
- (2014) Ignacio Melero et al. Nature Reviews Clinical Oncology
- Titrating T-Cell Epitopes within Self-Assembled Vaccines Optimizes CD4+ Helper T Cell and Antibody Outputs
- (2014) Rebecca R. Pompano et al. Advanced Healthcare Materials
- Self-Adjuvanting Synthetic Antitumor Vaccines from MUC1 Glycopeptides Conjugated to T-Cell Epitopes from Tetanus Toxoid
- (2013) Hui Cai et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- The use of self-adjuvanting nanofiber vaccines to elicit high-affinity B cell responses to peptide antigens without inflammation
- (2013) Jianjun Chen et al. BIOMATERIALS
- An update on safety and immunogenicity of vaccines containing emulsion-based adjuvants
- (2013) Christopher B Fox et al. Expert Review of Vaccines
- Oncology Meets Immunology: The Cancer-Immunity Cycle
- (2013) Daniel S. Chen et al. IMMUNITY
- Persistent antigen at vaccination sites induces tumor-specific CD8+ T cell sequestration, dysfunction and deletion
- (2013) Yared Hailemichael et al. NATURE MEDICINE
- Key roles of adjuvants in modern vaccines
- (2013) Steven G Reed et al. NATURE MEDICINE
- Nivolumab plus Ipilimumab in Advanced Melanoma
- (2013) Jedd D. Wolchok et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dipeptides promote folding and peptide binding of MHC class I molecules
- (2013) S. K. Saini et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Incorporation of d-alanine into poly(ethylene glycol) and l-poly(alanine-co-phenylalanine) block copolymers affects their nanoassemblies and enzymatic degradation
- (2013) Min Kyung Joo et al. Soft Matter
- Self-Assembled Peptide Amphiphile Micelles Containing a Cytotoxic T-Cell Epitope Promote a Protective Immune Response In Vivo
- (2012) Matthew Black et al. ADVANCED MATERIALS
- Dendritic cell activation and T cell priming with adjuvant- and antigen-loaded oxidation-sensitive polymersomes
- (2012) Evan A. Scott et al. BIOMATERIALS
- a Totally Synthetic, Self-Assembling, Adjuvant-Free MUC1 Glycopeptide Vaccine for Cancer Therapy
- (2012) Zhi-Hua Huang et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Disparate adjuvant properties among three formulations of “alum”
- (2012) Derek W. Cain et al. VACCINE
- Alum adjuvant: some of the tricks of the oldest adjuvant
- (2011) M. Kool et al. JOURNAL OF MEDICAL MICROBIOLOGY
- Adjuvanticity of the oil-in-water emulsion MF59 is independent of Nlrp3 inflammasome but requires the adaptor protein MyD88
- (2011) A. Seubert et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Uptake of particulate vaccine adjuvants by dendritic cells activates the NALP3 inflammasome
- (2009) Fiona A. Sharp et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A self-assembling peptide acting as an immune adjuvant
- (2009) J. S. Rudra et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started